ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998